Inventor · disambiguated record
Martin Huelsmeyer
Also filed as: HUELSMEYER MARTIN
12 granted patents·6 pending applications·101 citations·filing 2007–2020
91Inventor score
Files withPIERIS PHARMACEUTICALS GMBH10JENSEN KRISTIAN2GEN ELECTRIC1HOHLBAUM ANDREAS1MATSCHINER GABRIELE1
Top patents by PatentIndex Score
18 records- 0191US10618941B2Muteins of human lipocalin 2 (Lcn2,hNGAL) with affinity for a given targetPIERIS PHARMACEUTICALS GMBH·Filed 2016·Granted Apr 14, 2020·6 cites·20 claims
- 0290US9549968B2Muteins of human lipocalin 2 (LcnC,hNGAL) with affinity for a given targetSKERRA ARNE·Filed 2010·Granted Jan 24, 2017·21 cites·37 claims
- 0390US9051382B2Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding suchTRENTMANN STEFAN·Filed 2011·Granted Jun 9, 2015·26 cites·13 claims
- 0489US10273275B2Muteins of human lipocalin 2 with affinity for glypican-3 (GPC3) and methods of use thereofPIERIS PHARMACEUTICALS GMBH·Filed 2016·Granted Apr 30, 2019·10 cites·20 claims
- 0589US10046027B2Muteins of tear lipocalin and methods for obtaining the samePIERIS PHARMACEUTICALS GMBH·Filed 2015·Granted Aug 14, 2018·8 cites·14 claims
- 0688US8313924B2Muteins of tear lipocalin and methods for obtaining the sameJENSEN KRISTIAN·Filed 2007·Granted Nov 20, 2012·14 cites·44 claims
- 0787US10526384B2Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereofPIERIS PHARMACEUTICALS GMBH·Filed 2013·Granted Jan 7, 2020·5 cites·16 claims
- 0883US9212208B2Muteins with tear lipocalin having affinity to human c-Met receptor tyrosine kinase and methods for obtaining the sameMATSCHINER GABRIELE·Filed 2009·Granted Dec 15, 2015·6 cites·22 claims
- 0981US9221887B2Muteins of tear lipocalin and methods for obtaining the sameJENSEN KRISTIAN·Filed 2012·Granted Dec 29, 2015·5 cites·14 claims
- 1064US11827681B2Muteins of human lipocalin 2 (Lcn2, hNGAL) with affinity for a given targetPIERIS PHARMACEUTICALS GMBH·Filed 2020·Granted Nov 28, 2023·0 cites·21 claims
- 1160US10787491B2Nucleic acid molecules encoding muteins of human lipocalin 2 with affinity for glypican-3 (GPC3)PIERIS PHARMACEUTICALS GMBH·Filed 2019·Granted Sep 29, 2020·0 cites·11 claims
- 1260US2020148733A1Novel interleukin-17a-specific and interleukin-23-specific binding polypeptides and uses thereofPIERIS PHARMACEUTICALS GMBH·Filed 2019·Application pending·0 cites
- 1359US2019015477A1Muteins of tear lipocalin and methods for obtaining the samePIERIS PHARMACEUTICALS GMBH·Filed 2018·Application pending·0 cites
- 1456US2009274623A1In vivo imaging agents for met receptor tyrosine kinaseGEN ELECTRIC·Filed 2008·Application pending·0 cites
- 1552US2017369542A1Human neutrophil gelatinase-associated lipocalin (hngal) muteins that bind hepcidin and nucleic acid encoding suchPIERIS PHARMACEUTICALS GMBH·Filed 2017·Application pending·0 cites
- 1649US9751920B2Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the samePIERIS PHARMACEUTICALS GMBH·Filed 2015·Granted Sep 5, 2017·0 cites·2 claims
- 1746US2015291675A1Human neutrophil gelatinase-associated lipocalin (hngal) muteins that bind hepcidin and nucleic acid encoding suchPIERIS AG·Filed 2015·Application pending·0 cites
- 1830US2012201873A1Controlled release formulations of lipocalin muteinsHOHLBAUM ANDREAS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Huelsmeyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →